Universität zu Köln

2020

Carles, J., Alcaraz, A., Clarke, N. W., Conde, A., Heidenreich, A., Juarez, A., Maroto Rey, J. P., Puente, J., Hernandez-Medrano, I., Salcedo, I., Haddad, I., Munoz del Toro, J., Servan, A., Pissart, G., Casariego, J. and Fizazi, K. (2020). ORACULUM: A retrospective observational epidemiological study using artificial intelligence and natural language processing in electronic health records to characterize the prostate cancer pathway, management and outcomes in Europe, Middle East and Africa (EMEA region). Ann. Oncol., 31. S. S549 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041

2018

Miller, K., Heinrich, D., O'Sullivan, J. M., Carles, J., Wirth, M., Nilsson, S., Huang, L., Kalinovsky, J., Heidenreich, A. and Saad, F. (2018). Radium-223 (Ra-223) therapy after abiraterone (Abi): Analysis of symptomatic skeletal events (SSEs) in an international early access program (iEAP) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). Ann. Oncol., 29. S. 287 - 288. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041

2017

Zastrow, S., Saad, F., Heinrich, D., Gillessen, S., OSullivan, J., Carles, J., Miller, K., Huang, L., Van Tol, Seeger M., Nilsson, S. and Heidenreich, A. (2017). Radium-223 (Ra-223) in sequence or in concurrent use with abiraterone acetate (AA) or enzalutamide (E) in metastatic castration resistant prostate cancer (mCRPC) patients treated in an international early access program (iEAP). Oncol. Res. Treat., 40. S. 94 - 95. BASEL: KARGER. ISSN 2296-5262

2016

Heidenreich, A., O'Sullivan, J., Gillessen, S., Heinrich, D., Gratt, J., Levy, J., Miller, K., Nilson, S., Saad, F., Tucci, M., Wirth, M. and Carles, J. (2016). Effects of concomitant use of abiraterone and/or enzalutamide with radium-223 on safety and overall survival in metastatic castration resistant prostate cancer (mCRCP) patients treated in an international early access program (EAP). Oncol. Res. Treat., 39. S. 86 - 88. BASEL: KARGER. ISSN 2296-5262

Heinrich, D., Gillessen, S., Heidenreich, A., Keizman, D., O'Sullivan, J. M., Carles, J., Wirth, M., Miller, K., Procopio, G., Gratt, J., Seger-Van Tol, M., Nilsson, S. and Saad, F. (2016). Changes in alkaline phosphatase (ALP) dynamics and overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC) patients treated with radium-223 in an international early access program (EAP). Ann. Oncol., 27. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041

Saad, F., Heidenreich, A., Heinrich, D., Keizman, D., O'Sullivan, J. M., Carles, J., Wirth, M., Miller, K., Gratt, J., Seger-Van Tol, M., Nilsson, S. and Gillessen, S. (2016). Radium-223 with concomitant bone-targeting agents in metastatic castration-resistant prostate cancer (CRPC) patients treated in an international early access program (EAP). Ann. Oncol., 27. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041